tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Genmab A/S (GB:0MGB)
LSE:0MGB
UK Market
0MGB
Genmab A/S
RESEARCH TOOLSreports

Genmab A/S (0MGB) Stock News & Sentiment

Compare
12 Followers
Genmab A/S: Promising Growth Prospects with Strategic Catalysts and Robust Pipeline
Premium
Ratings
Genmab A/S: Promising Growth Prospects with Strategic Catalysts and Robust Pipeline
10d ago
GMAB
Genmab’s Growth Potential Boosted by Early FDA Approval of Epkinly for Lymphoma Treatment
Premium
Ratings
Genmab’s Growth Potential Boosted by Early FDA Approval of Epkinly for Lymphoma Treatment
22d ago
GMAB
Genmab’s Strong Financial Performance and Promising Pipeline Reinforce Buy Rating
Premium
Ratings
Genmab’s Strong Financial Performance and Promising Pipeline Reinforce Buy Rating
1M ago
GMAB
Genmab’s Promising Colorectal Cancer Treatment Drives Buy Rating
Premium
Ratings
Genmab’s Promising Colorectal Cancer Treatment Drives Buy Rating
2M ago
GMAB
Promising Clinical Developments in Genmab’s Portfolio Reinforce Buy Rating
Premium
Ratings
Promising Clinical Developments in Genmab’s Portfolio Reinforce Buy Rating
2M ago
GMAB
Genmab’s Oncology Advancements and Strategic Positioning Drive Buy Rating
Premium
Ratings
Genmab’s Oncology Advancements and Strategic Positioning Drive Buy Rating
2M ago
GMAB
Genmab’s Strong Market Position and Growth Potential Justify Buy Rating with $40 Price Target
Premium
Ratings
Genmab’s Strong Market Position and Growth Potential Justify Buy Rating with $40 Price Target
2M ago
GMAB
More GB:0MGB News >

0MGB News on the Web

UBS Sticks to Their Buy Rating for Genmab A/S (0MGB)
TipRanks News
Neutral
Genmab A/S (0MGB) Receives a Hold from Kepler Capital
TipRanks News
Neutral
Truist Financial Remains a Buy on Genmab (GMAB)
TipRanks News
Neutral
Leerink Partners Reaffirms Their Buy Rating on Genmab (GMAB)
TipRanks News
Neutral
Truist Financial Reaffirms Their Buy Rating on Genmab (GMAB)
TipRanks News
Neutral
European stocks set to open higher; Lufthansa plans to cut 4,000 jobs
CNBC
Neutral
Bernstein Remains a Sell on Genmab (GMAB)
TipRanks News
Neutral
Genmab A/S (0MGB) Receives a Hold from Goldman Sachs
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
GB:0MGB
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0MGB’s Media Buzz Sentiment?
1 articles about GB:0MGB were published this week. In an average week, 1 articles are published.
    What is GB:0MGB’s weekly average amount of articles?
    In an average week, 1 articles about GB:0MGB are published.
      What is GB:0MGB’s News Sentiment?
      50% of articles about GB:0MGB were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        HUMHumana
        XCURExicure
        WVEWave Life Sciences
        STAAStaar Surgical
        COOCooper Co
        Showing the stocks with the most bullish news sentiment over the past week